ROTATION DESCRIPTION - PGY1 Adult Internal Medicine

Similar documents
ROTATION DESCRIPTION

ROTATION DESCRIPTION

ROTATION DESCRIPTION FORM PGY1

Florida A&M University College of Pharmacy & Pharmaceutical Sciences

PGY 1 Pharmacy Residency Cardiology Experience Description Truman Medical Center Hospital Hill

APPE Acute Care Rotation Evaluation of Student

Medical Intensive Care Unit Rotation EUHM

Neurocritical Care Rotation - EUH

Neurology Clinic - Ambulatory Care I & II

UNMC COLLEGE OF PHARMACY ADVANCED PHARMACY PRACTICE EXPERIENCE SYLLABUS (Revised November 2014)

Stellar Hospital PGY-1 Pharmacy Residency

UNMC COLLEGE OF PHARMACY ADVANCED PHARMACY PRACTICE EXPERIENCE (APPE) SYLLABUS (Revised February 2013, Approved April 2013)

Acute Care Cardiology Learning Description at Emory University Hospital Midtown (EUHM)

PGY1 Course Description

UNMC COLLEGE OF PHARMACY ADVANCED PHARMACY PRACTICE EXPERIENCE (APPE) SYLLABUS (November 2014) (Approved December 2014)

Liver EUH Learning Activities:

American Journal of Pharmaceutical Education 2003; 67 (3) Article 88.

Ambulatory Care Advanced Pharmacy Practice Experience Course Title: PHAR 9981

Acute Care Advanced Pharmacy Practice Experience SPPS 400A SPPS 400B

SPE IV: Pharmacy 500X Preceptor s Evaluation of Student 2018

Professional Student Outcomes (PSOs) - the academic knowledge, skills, and attitudes that a pharmacy graduate should possess.

Block Title: Patient Care Experience Block #: PHRM 701, 702, 703, 704 and PHRM 705, 706, and 707 (if patient care)

UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2017 October 1 st, 2016

Antimicrobial EUHM Learning Activities:

PGY1 Oncology 2 Advanced Learning Experience

Ambulatory Care Advanced Pharmacy Practice Experience SPPS 401A SPPS 401B

PGY1: Pediatric Cardiovascular Intensive Care Unit Riley Hospital for Children at Indiana University Health

PGY1 Medication Safety Core Rotation

Neonatal Intensive Care Unit EUHM

FERRIS STATE UNIVERSITY COLLEGE OF PHARMACY APPROVED BY FACULTY AUGUST 20, 2014

Experiential Education

Learning Experiences Descriptions

University of Utah PGY-1 Pharmacy Practice Primary Care: Ambulatory I & II Rotation Salt Lake City, Utah

Disease State Management Clinics: A Pharmacist Perspective

Liver Transplant EUH Learning Activities:

COMBINED INTERNAL MEDICINE & PEDIATRICS Department of Medicine, Department of Pediatrics SCOPE OF PRACTICE PGY-1 PGY-4

CAPE/COP Educational Outcomes (approved 2016)

Introductory to Pharmacy Practice Experience Summer Experience Florida A&M University College of Pharmacy and Pharmaceutical Sciences

Community Pharmacy Advanced Pharmacy Practice Experience SPPS 402

Practice Tools for Safe Drug Therapy

P1 Fall SCCP 602/COP 601: Foundations of Pathophysiology and Pharmacology I This is the first course in a 2-semester sequence providing important

WRNMMC Nephrology Rotation 2013

COURSE TITLE: Adult Medicine: Phar 9981

College of Pharmacy. Pharmacy Practice and Science

Infectious EUH Learning Activities:

Prepared Jointly by the American Society of Health-System Pharmacists and the Academy of Managed Care Pharmacy

Developing a Syllabus

PGY1 Oncology Rotation

Course Descriptions for PharmD Classes of 2021 and Beyond updated November 2017

SPE III: Pharmacy 403W Preceptor s Evaluation of Student

Colorado Board of Pharmacy Rules pertaining to Collaborative Practice Agreements

Curricular area: Specific Rotations: Responsible faculty: Goals: Setting: Key to Competencies Teaching activities: Level of supervision:

Department of Pharmacy Services PGY1 Residency Program. Residency Manual

Bethesda Hospital PGY1 Residency Program Learning Experiences

PGY2 AMBULATORY CARE PHARMACY RESIDENCY MEDICAL UNIVERSITY OF SOUTH CAROLINA

SICU Curriculum for CA2 West Virginia University Department of Anesthesiology

Integrating the LLM / JCPP-PPCP Seena Haines, PharmD, BCACP, FASHP, FAPhA, BC-ADM, CDE Jenny A. Van Amburgh, PharmD, RPh, FAPhA, BCACP, CDE

Incorporating the Pharmacists Patient Care Process into Practice

Howard University College of Pharmacy. Preceptor Orientation May 2012

Educational Outcomes, Goals, and Objectives for Postgraduate Year Two (PGY2) Pharmacy Residencies in Emergency Medicine

Pediatric Cardiology Rotation PL-1 Residents

MISSION, VISION AND GUIDING PRINCIPLES

Policies and Procedures for In-Training Evaluation of Resident

PGY-2 PEDIATRIC PHARMACY RESIDENCY MEDICAL UNIVERSITY OF SOUTH CAROLINA

Drug EUHM Learning Activities:

Hospital / Health-System Advanced Pharmacy Practice Experience SPPS 403

APPROACHES TO ENHANCING THE QUALITY OF DRUG THERAPY A JOINT STATEMENT BY THE CMA ANDTHE CANADIAN PHARMACEUTICAL ASSOCIATION

OUTPATIENT LIVER INTRODUCTION:

Adult Hematology Residency Training Program

PGY1: Pediatric Infectious Diseases Riley Hospital for Children Indiana University Health

APPE Pharmacy Student Elective. Cardiology

University of Illinois College of Medicine SURGERY CLERKSHIP STUDENT EVALUATION FORM

Goal #1: Mastery of Clinical Knowledge with Integration of Basic Sciences

University Campus PGY1 Pharmacy Residency. The University of Arizona Medical Center University Campus

Disclosures. Objectives. Leveraging and Developing Your Team for Optimal Outcomes. None

Educational Outcomes, Goals, and Objectives for Postgraduate Year Two (PGY2) Pharmacy Residencies in Internal Medicine

Elective: General Surgical - Green Service (Oncology)

Precepting Advanced Pharmacy NEOMED TEMPLATE. Practice Experiences (APPEs)

Required Educational Outcomes, Goals, and Objectives for Postgraduate Year Two (PGY2) Pharmacy Residencies in Solid Organ Transplant

SPE II: Pharmacy 302W Preceptor s Evaluation of Student

Park Nicollet Medication Management

Managed Care Pharmacy Practice Residency

Clinical Cardiology Adult Congenital Heart Disease Clinical Service (1 month)

OVERALL GOALS & OBJECTIVES FOR EACH RESIDENT LEVEL

UNDERSTANDING THE CONTENT OUTLINE/CLASSIFICATION SYSTEM

1) Goal Fellows will become competent in caring for renal transplant patients and patients with renal complications of non-renal transplants.

HEMATOLOGY / ONCOLOGY

TORONTO GENERAL HOSPITAL/ McGILL UNIVERSITY HEALTH CENTRE HIV SPECIALTY RESIDENCY PROGRAM CLINICAL ROTATION RESIDENT ASSESSMENT FORM

PROFESSIONAL NURSE. Description of Work: Definition. Competency

Administration ~ Education and Training (919)

Course: Acute Trauma Care Course Number SUR 1905 (1615)

Educational. PPCP Foundations 3/5/17. Integrating the LLM / JCPP-PPCP in Experiential Education. Session Objectives

2110 Pediatric Newborn Care

Pharmacy Leadership and Administration Learning Experience Rev 12/16/16

Essential Skills and Abilities Requirements for Admission, Promotion, and Graduation in the Pharmacy Program

SCOPE OF PRACTICE PGY-2 PGY-5

PGY1 - Project Learning Experience Description

Evanston General Pediatrics Inpatient Rotation PL-2 Residents

Preceptor Development: Patient Care Process. Introduction

Hematology Inpatient Rotation II Foothills Medical Centre

Transcription:

ROTATION DESCRIPTION - PGY1 Adult Internal Medicine PURPOSE The IM rotation provides the opportunity for PGY1 residents to improve their knowledge base and pharmacotherapeutic skills while enhancing care for acutely ill patients. The resident will become familiar with the pharmacotherapy for the most commonly encountered disease states, review major guidelines and landmark trials for relevant disease states, and participate in the education of team members and patients. PGY1 residents will work with one internal medicine team. LEARNING EXPERIENCE DESCRIPTION This rotation will provide exposure to a broad range of disease states and patient populations. The pharmacy resident is expected to provide comprehensive pharmaceutical care for one team, including prospective drug utilization review, providing recommendations to the team to improve pharmacotherapy, coordinating pharmaceutical services when needed, and counseling patients upon admission and/or discharge when appropriate. The internal medicine team consists of internal medicine attending, an upper level medicine resident, two interns (1 st year medical residents), a case manager, dietician, nurses, and a Pharm.D. The resident will spend five days a week with the internal medicine team. The team generally meets on 8E, though patients may be located throughout the hospital, and the census varies. The team is on call every other day. Rounds generally start around 9:00 or 9:30 a.m. and last until noon. The preceptor will round with the resident as often as possible until such time as the resident is comfortable rounding independently. After that time, the preceptor will round with the resident routinely but not every day. However, the role of the preceptor will shift from a model to a coach/facilitator, and the resident is expected to assume the responsibility of provided excellent pharmaceutical care for all patients. Residents may discuss patients briefly with the preceptor prior to rounds, during downtime on rounds, and in more depth after rounds. If the preceptor provides order verification for the team s orders, the resident will incorporate that activity into their routine at the discretion of the preceptor if a computer is available. The resident will lead or participate in topic discussions and literature evaluation at least twice weekly, including team teaching and journal club. When students are also on rotation, the resident will assist in supervision and education, the degree of which will be determined on a mutual basis between the preceptor, resident, and student. LEARNING EXPERIENCE ACTIVITIES The following activities are required during the internal medicine rotation for a PGY1 resident. Activities directly related to RLS objectives evaluated on this rotation are noted. 1. Collect and interpret data to apply to patient care, including the following activities: (R2.2.1; 2.4.1) a) Interpret and integrate relevant subjective and objective information in disease state management. When necessary, review articles or other information to enhance understanding of the data.

b) Collect, interpret, and integrate relevant subjective and objective information in disease state management including age, allergies, weight, past medical history, etc. (R2.4.3; 2.6.2; 2.7.1; 2.10.1; 2.10.2 ) c) Obtain or review a medication history for selected patients, based on an assessment of need (e.g, those with possible drug-induced diseases or ADRs, drug interactions, complex regimens including high risk drugs, suspected nonadherence, methadone, etc.). Depending on service volume, the resident can expect to perform at least 2-3 med histories per week. (R2.9.2) d) Review, monitor, and modify therapeutic regimens considering the following components: adherence, interactions, adverse drug reactions, efficacy, toxicity, appropriate drug and dosing, and duplicate therapy. (R1.4.1; 2.4.2; 2.7.1, 2.10.1; 2.10.2) e) Prepare and maintain a monitoring system for each patient; and use this tool to monitor patients drug regimens and present a patient in a concise and organized manner. It is likely that the service will include 6-20 patients each day, with 3-8 new admissions every other day. (R2.4.3; 2.7.1) 2. Design and implement a pharmacotherapeutic plan. a) Apply knowledge of pathophysiology, signs and symptoms, diagnosis and pharmacotherapy of specific disease states. Develop medication management plans to ensure positive patient outcomes, therapeutic endpoints, and costeffectiveness. Apply guidelines routinely and begin to incorporate relevant primary literature when possible. (R2.1.1; 2.6.1; 2.6.2; 2.10.1) b) Develop medication management plans to ensure positive patient outcomes, therapeutic endpoints, and cost-effectiveness. c) Implement a reasonable patient care plan using problem-solving skills, contacting health care professionals, following up as needed and reassessing plans. (R2.1.1; 2.2.1; 2.7.1; 2.8.1; 2.9.1; 2.10.2) a) Identify medication errors and adverse drug reactions. Discuss with the team and/or the patient when necessary. (R1.4.1; 2.2.1; 2.4.2; 2.7.1; 2.10.2) d) Counsel patients prior to discharge, emphasizing new medications or medications for which lack of comprehension is likely to have serious consequences. Discharge counseling is preferred for all patients and mandatory for all inhalers, anticoagulants, and antibiotics. (R2.2.1; 2.4.2; 2.8.1; 2.9.2) 3. Build and apply his or her fund of knowledge. (R2.4.2) a) Analyze clinical drug guidelines and current practice standards in the context of developing medication management plans. (R2.6.1) b) Demonstrate technical drug knowledge including pharmacokinetics, mechanism of action, administration, adverse reactions, contraindications, interactions, and formulations. (R2.6.2; 2.7.1; 2.10.1; 2.10.2) c) Display understanding of the role of pharmacists in monitoring therapy and assessing medication orders in the institutional setting. (R2.1.1; 2.6.1; 2.10.1; 2.10.2) d) Participate in team teaching. The entails preparation/reading for all topics (6-9 per month) and presenting, or possibly precepting a junior learner in presenting, 1-2 topics. e) Participate in journal club. The resident should read all articles (2-3 per month) prior to the meeting, contribute to discussion of the articles, and possible present 1

article. Also, the resident may present a pearl from a rotation or on call experience. (R2.6.1; 2.6.2, 5.1.3) 4. Improve communication skills a) Communicate effectively and professionally with patients and healthcare professionals. Understand continuity of care between health care settings. When a patient transfers to another service, or is discharged with anticipation of outpatient care within the MUSC system, the resident should contact the appropriate provider to share pertinent information that will enhance patient care. This may occur via phone, face-to-face, or electronic communication. The resident will likely have this opportunity 1-5 times per week. (R2.1.1; 2.4.1; 2.4.2; 2.8.1; 2.9.2; 5.1.3) b) Effectively present oral/written communications, including patient consultations, drug information responses, and progress notes. (R2.8.1; 2.10.1) c) Use appropriate terminology, provide accommodations (language, hearing, etc) for intended audience. (R2.4.2; 2.8.1; 2.9.2; 5.1.3) d) Practice active listening, empathy and compassion using nonverbal communication techniques. (R2.1.1; 2.9.2; 5.1.3) e) Seek and provide conflict resolution promptly. (R2.1.1; 5.1.3) 5. Document appropriately. (R2.2.1) a) Any addendum to the medication history should be noted in the chart, preferably via an e-note (likely to occur at least once a week). b) Progress notes, preferably e-notes, should be written in order to enhance communication; topics include but are not limited to pharmacokinetics and direct thrombin inhibitors. The resident should expect to write several notes each week, but this may vary with patient census and therapies. (R2.7.1; 2.8.1) c) Discharge counseling will be documented either in the progress notes or any other specified location. The resident should expect to document several counseling sessions each week, but this may vary with patient census and therapies. d) (R2.4.2; 2.8.1) e) Relevant interventions must be documented in emeds. The anticipated volume is approximately 10 per week. When a medication allergy or reaction occurs, ensure that the patient profile is updated in the pharmacy system. f) Medication errors and adverse drug reactions must be reported in patient safety net. In addition, the resident should discuss all reports with the preceptor. (R1.4.1; 2.4.2; 2.7.1) 6. Display professional behavior and attitude a) Give advance notification of illness or schedule conflict. b) Dress appropriately (ID badge required) and conduct oneself in a manner consistent with professional standards. If the resident does not have his/her pager, the resident should obtain a loaner from paging services in a timely fashion. c) Effectively use his/her time. Follow through on assigned tasks in a conscientious manner. (R2.2.1) d) Demonstrate and accept responsibility. e) Maintain confidentiality and an awareness of ethical and legal standards (R2.2.1; 2.6.2)

f) Display respect and empathy for patients and other health care professionals. (R2.1.1) g) Establish trust, confidence, and rapport with patients and interdisciplinary team. (R2.1.1; 2.4.2, 2.8.1) h) Embrace life long learning and plans for future continuing education through career. Demonstrate intellectual curiosity, initiative, integrity, and cooperation. REQUIREMENTS OF LEARNING EXPERIENCE Required Hours Generally the resident will need to be present from 7 am to 5 pm. These hours may vary based on the resident s efficiency, activities occurring that day, and non-rotation activities. The resident shall alert the preceptor if they anticipate they will exceed the resident work hours set forth in the ACGME policy on resident work hours. Required Meetings Daily rounds Medicine Grand Rounds: Tuesdays 8-9 am at the IOP auditorium Medicine Journal Club: 2-4 pm, 3rd Wednesday each month Pharmacy Resident Seminar: Mondays, 1:00-2:00pm Pharmacy Resident Rite presentations: Fridays, 12:00-1:00pm Medicine Team Teaching: see calendar, usually 2-4pm Mondays and Thursdays Any other learning opportunity designated by the RPD or preceptor Optional activities: Depending on the team dynamics, attending preferences, and patient census, the resident may present one or more inservices to the team or a nursing group. If a student is on rotation, the resident may co-precept the student s presentation at the primary preceptor s discretion. The resident may present at medicine journal club (at the request of the preceptor) or co-precept a student s presentation. In addition, when BAT, MET, or codes are called for a patient on the resident s service and (s)he is aware of the emergency, the resident may participate (to the extent possible) in the pharmaceutical care of the patient. Pharmacy Grand Rounds: Wednesdays, 12:00-2:00pm Morning Report: Mon, Wed, Fri 8:30-9:30 a.m. CSB 305 Noon Conference: daily at noon CSB 305 ROTATION PRECEPTOR Nicole Bohm Assistant Professor, Internal Medicine Pager ID: 13172 Phone: 792-7523 Email address: bohm@musc.edu Tracie Delay Clinical Pharmacy Specialist, Internal Medicine Pager ID: 11004 Phone: 792-7518 Email address: bohm@musc.edu

METHOD OF EVALUATION Evaluation of resident will be based on the RLS goals assigned by the Residency Program Director (RPD) in resi-trak. The preceptor and resident will review the resident s customized plan and the learning experience introduction document on the first day of rotation. Feedback will include, but not be limited to, verbal and written midpoint and end of rotation evaluations. The resident will receive formal written and verbal evaluation approximately two weeks after starting the rotation and within 3 days of completing the rotation, usually on the final day of the rotation. The final evaluation will reflect the goals and objectives identified for the rotation in E-Value. Evaluations will incorporate feedback from the interdisciplinary team when available. In addition, the preceptor will make every attempt to provide informal feedback to the resident throughout the month. The resident is encouraged to seek feedback at any time. The resident is expected to provide verbal feedback to the preceptor regarding any areas of the rotation that could be improved to enhance the rotation, both for the month and in the future, at the midpoint and final evaluations. Interim feedback is welcome.